O’Melveny & Myers LLP represented China-based BGI-Shenzhen, a leading international genomics company, in entering into a definitive merger agreement with Complete Genomics, Inc. The transaction is valued at approximately US$117.6 million.
The O’Melveny team was led by San Francisco-based partner Paul Scrivano and Shanghai-based counsel Wendy Pan.
